Akebia Therapeutics, Inc.
AKBA$0.9703▲ 0.06% 24h
Akebia Therapeutics, Inc.AKBA$0.9703
-$0.1158(-10.66%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$259.92M
P/E ratio
—
EPS (diluted)
$-0.02
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$236.20M
Net income
$-5.34M
Net margin
-2.3%
Gross margin
—
Dividends & financials
Akebia Therapeutics, Inc. (AKBA) reported revenue of $236.20M and net income of $-5.34M, or $-0.02 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.